How this hedge fund pulled off 2023’s ‘big short’

Last year, Ravi Chopra was travelling through Europe to shop his latest short idea to potential investors. “Financials are really all in the weeds,” he told The Australian Financial Review in an interview from New York.

Joshua Peach

How this hedge fund pulled off 2023’s ‘big short’

October 16, 2023
Last year, Ravi Chopra was travelling through Europe to shop his latest short idea to potential investors. “Financials are really all in the weeds,” he told The Australian Financial Review in an interview from New York.
Read Transcript

Azora Capital’s Ravi Chopra says there were early signs of the drama about to unfold in the banking sector. Picture: Jaclyn Licht

 

Last year, Ravi Chopra was travelling through Europe to shop his latest short idea to potential investors.

His New York hedge fund, Azora Capital, was betting against a handful of US banks and the chief investment officer had a stack of slides with him to make his case.

One slide in the presentation read: “No way out.”

“A lot of investors would look at me, quizzically, and say: ‘How could these highly regulated, sophisticated financial institutions make such an obvious mistake?’” Chopra said.

The mistake the banks had made, which Chopra and his team had uncovered, was three years, trillions of stimulus dollars and 500 basis points of US interest rate rises in the making.

Those factors materialised after the pandemic, as the US Federal Reserve cut and then raised interest rates at historic speeds while the government rolled out a record $US5 trillion ($7.9 trillion) of stimulus measures to manage the economy through the crisis.

All this amounted to what Chopra called “the ingredients for a banking crisis”, a recipe he had become familiar with during his 20-year career specialising in financial institutions.

Chopra started as a researcher in the financial services arm of Goldman Sachs in 2001 and quickly fell in love with the sector.

“Financials are really all in the weeds,” he told The Australian Financial Review in an interview from New York. “It’s all about numbers, it’s about modelling. It’s not just about looking at an earnings reports, but also looking at any regulatory data that we can get our hands on. I was hooked.”

Eventually making the shift to the buy side, Chopra joined hedge fund Sigma Capital in 2007 just in time to witness a series of bad loans in the US real estate market trigger the worst global banking crisis since the Great Depression.

“That’s really where I honed my skills in investing in this unique space,” he said.

“We were basically picking through companies that had taken the pain upfront and could withstand it and looking for those that, when we ran it out over two years, were clearly capital deficient and would either have to raise capital at distressed levels or simply wouldn’t make it.”

After riding the global financial crisis with Sigma, Chopra moved on to help launch a new venture, Samlyn Capital, as a partner and the firm’s head of US financial services.

When history rhymes
A few years later, Chopra began to consider starting a standalone financial services hedge fund.

“I looked around and there were so many sector funds, but there really weren’t many with real dedication to financial services,” he said.

“Even generalist long-short funds tended to shy away from financials. They’re hard, complicated and regulated. They’re also cyclical, opaque and highly levered. All those things are absolutely true, but that’s what we love about the space.”

Azora Capital launched in the back half of the 2010s, and as markets ticked over into the new decade, Chopra started to see echoes of 2008 emerge when the Fed started lifting rates last year.

“History was absolutely rhyming. Things were looking pretty similar, but the drivers were different,” he added.

“Back in the GFC it was all about credit and capital, and so for the last 15 years, bank management teams, regulators and rating agencies have been doing stress testing around those issues.”

But while the industry was focused on credit threats, Chopra believed not enough attention was being paid to the other key factor driving financial institutions – interest rates.

“Over the last 15 years, many of those financial institutions were quietly trading out credit risk for interest rate risk. Credit risk was the problem of yesteryear.”

And by late 2022, those interest rate risks were ballooning fast. Much of that $US5 trillion of stimulus that had taken place during the pandemic had found its way onto bank balance sheets.

“Typically, industry-wide bank deposits grow about 6 per cent per year. It’s usually very steady but in those two years, bank deposits grew by 35 per cent.”

Looking around, Chopra saw that some banks, much like the American citizens stuck at home during the pandemic, had gone on a stimulus-led shopping spree.

“But they weren’t buying Peloton bikes, they bought things like Treasury securities at the lowest yields in the history of the United States. And so they had to go out to 10- or 15-year maturity schedules to get any kind of yield,” the CIO said.

“Banks that touched growth industries like technology, biotech and crypto doubled, tripled, or even grew eight times in size in two years. That was wholly unnatural in financial services.”

So, why did the banks take on the risk? According to Chopra, bank treasurers simply weren’t expecting what happened next.

“Ever since the GFC, regulators mandate that most of the systematically important banks undergo stress testing. In their worst-case test assumptions, the stockmarket goes down 50 per cent, real estate prices drop 40 per cent and unemployment goes to 10 per cent.

“But in their interest rate assumptions, the cash rate goes from 70 basis points to just 1.5 per cent. That was their worst-case scenario – 80 bps.”

So when the US Fed began ratcheting up rates by hundreds of basis points in 2022 and 2023, the bond portfolios of some banks were suddenly losing value fast.

No way out
Rising rates had pushed the market value of the banks’ long-duration bond portfolios negativejust as deposits had started fleeing bank accounts to other alternatives. That meant those banks that hadn’t insured their deposit base were suddenly facing a liquidity crunch.

“Credit losses maim, but its really liquidity that kills financial institutions,” Chopra said. “Much like the global financial crisis, many of the banks were undercapitalised and based on today’s standards, a number of them were actually mathematically insolvent.”

Chopra and his team began screening US banks for high levels of unrealised bond losses and low levels of deposit insurance, and four names rose to the top – Silvergate, Silicon Valley Bank, Signature Bank, and First Republic.

“All four of those banks had 70 to 90 per cent of their deposit bases uninsured, which is measurably higher than the rest of the industry,” he said.

By March 2023, cracks were emerging and crypto bank Silvergate fell, following the failure of major depositor FTX, the now defunct crypto exchange founded by Sam Bankman-Fried.

The Silvergate collapse sparked widespread liquidity concerns, particularly in start-up and cryptocurrency exposed financial institutions.

Silicon Valley Bank was the next to fall after announcing plans to sell one of its smaller $US20 billion portfolios of US Treasuries at a $US2 billion loss.

“Depositors started getting really nervous and that led to a quiet but deadly electronic run on the bank that happened during the course of an afternoon, as the stock price continued to fall,” Chopra said.

“And then ultimately, over the course of the weekend depositors became more concerned about deposits and other financial institutions and similar situations happened with Signature Bank on that Friday, and then ultimately with First Republic.”

Just like Chopra’s slide had warned a year earlier, the banks had no way out.

While SVB marked the largest US bank collapse in more than a decade, it also resulted in Azora Capital’s best monthly return since its inception.

“In 2008 and 2009, 165 banks failed, comprising half a trillion dollars of assets. In the spring of this year, four banks failed, comprising half a trillion dollars of assets,” Chopra said.

Six months on and the industry is still feeling the shock.

“We did a survey of the top 50 financial institutions in the spring, and over 70 per cent of them said that they were tightening underwriting standards. That’s something I haven’t actually seen in my career, certainly not since the GFC,” Chopra added.

Meanwhile, the hedge fund is back to work, combing through regulatory filing and financial models, looking for the next opportunity.

“It’s often in row 500 of the Excel model on Tuesday night at 10pm that the proverbial light bulb goes off over our heads. That’s where the epiphanies are, that’s our secret sauce.”

Ravi Chopra is speaking at Sohn Hearts & Minds at the Sydney Opera House on November 17. All profits will support Australian medical research organisations. The Australian Financial Review is a media partner for sohnheartsandminds.com.au.

This article was originally posted by The Australian Financial Review here.

Licensed by Copyright Agency. You must not copy this work without permission.

Azora Capital’s Ravi Chopra says there were early signs of the drama about to unfold in the banking sector. Picture: Jaclyn Licht

 

Last year, Ravi Chopra was travelling through Europe to shop his latest short idea to potential investors.

His New York hedge fund, Azora Capital, was betting against a handful of US banks and the chief investment officer had a stack of slides with him to make his case.

One slide in the presentation read: “No way out.”

“A lot of investors would look at me, quizzically, and say: ‘How could these highly regulated, sophisticated financial institutions make such an obvious mistake?’” Chopra said.

The mistake the banks had made, which Chopra and his team had uncovered, was three years, trillions of stimulus dollars and 500 basis points of US interest rate rises in the making.

Those factors materialised after the pandemic, as the US Federal Reserve cut and then raised interest rates at historic speeds while the government rolled out a record $US5 trillion ($7.9 trillion) of stimulus measures to manage the economy through the crisis.

All this amounted to what Chopra called “the ingredients for a banking crisis”, a recipe he had become familiar with during his 20-year career specialising in financial institutions.

Chopra started as a researcher in the financial services arm of Goldman Sachs in 2001 and quickly fell in love with the sector.

“Financials are really all in the weeds,” he told The Australian Financial Review in an interview from New York. “It’s all about numbers, it’s about modelling. It’s not just about looking at an earnings reports, but also looking at any regulatory data that we can get our hands on. I was hooked.”

Eventually making the shift to the buy side, Chopra joined hedge fund Sigma Capital in 2007 just in time to witness a series of bad loans in the US real estate market trigger the worst global banking crisis since the Great Depression.

“That’s really where I honed my skills in investing in this unique space,” he said.

“We were basically picking through companies that had taken the pain upfront and could withstand it and looking for those that, when we ran it out over two years, were clearly capital deficient and would either have to raise capital at distressed levels or simply wouldn’t make it.”

After riding the global financial crisis with Sigma, Chopra moved on to help launch a new venture, Samlyn Capital, as a partner and the firm’s head of US financial services.

When history rhymes
A few years later, Chopra began to consider starting a standalone financial services hedge fund.

“I looked around and there were so many sector funds, but there really weren’t many with real dedication to financial services,” he said.

“Even generalist long-short funds tended to shy away from financials. They’re hard, complicated and regulated. They’re also cyclical, opaque and highly levered. All those things are absolutely true, but that’s what we love about the space.”

Azora Capital launched in the back half of the 2010s, and as markets ticked over into the new decade, Chopra started to see echoes of 2008 emerge when the Fed started lifting rates last year.

“History was absolutely rhyming. Things were looking pretty similar, but the drivers were different,” he added.

“Back in the GFC it was all about credit and capital, and so for the last 15 years, bank management teams, regulators and rating agencies have been doing stress testing around those issues.”

But while the industry was focused on credit threats, Chopra believed not enough attention was being paid to the other key factor driving financial institutions – interest rates.

“Over the last 15 years, many of those financial institutions were quietly trading out credit risk for interest rate risk. Credit risk was the problem of yesteryear.”

And by late 2022, those interest rate risks were ballooning fast. Much of that $US5 trillion of stimulus that had taken place during the pandemic had found its way onto bank balance sheets.

“Typically, industry-wide bank deposits grow about 6 per cent per year. It’s usually very steady but in those two years, bank deposits grew by 35 per cent.”

Looking around, Chopra saw that some banks, much like the American citizens stuck at home during the pandemic, had gone on a stimulus-led shopping spree.

“But they weren’t buying Peloton bikes, they bought things like Treasury securities at the lowest yields in the history of the United States. And so they had to go out to 10- or 15-year maturity schedules to get any kind of yield,” the CIO said.

“Banks that touched growth industries like technology, biotech and crypto doubled, tripled, or even grew eight times in size in two years. That was wholly unnatural in financial services.”

So, why did the banks take on the risk? According to Chopra, bank treasurers simply weren’t expecting what happened next.

“Ever since the GFC, regulators mandate that most of the systematically important banks undergo stress testing. In their worst-case test assumptions, the stockmarket goes down 50 per cent, real estate prices drop 40 per cent and unemployment goes to 10 per cent.

“But in their interest rate assumptions, the cash rate goes from 70 basis points to just 1.5 per cent. That was their worst-case scenario – 80 bps.”

So when the US Fed began ratcheting up rates by hundreds of basis points in 2022 and 2023, the bond portfolios of some banks were suddenly losing value fast.

No way out
Rising rates had pushed the market value of the banks’ long-duration bond portfolios negativejust as deposits had started fleeing bank accounts to other alternatives. That meant those banks that hadn’t insured their deposit base were suddenly facing a liquidity crunch.

“Credit losses maim, but its really liquidity that kills financial institutions,” Chopra said. “Much like the global financial crisis, many of the banks were undercapitalised and based on today’s standards, a number of them were actually mathematically insolvent.”

Chopra and his team began screening US banks for high levels of unrealised bond losses and low levels of deposit insurance, and four names rose to the top – Silvergate, Silicon Valley Bank, Signature Bank, and First Republic.

“All four of those banks had 70 to 90 per cent of their deposit bases uninsured, which is measurably higher than the rest of the industry,” he said.

By March 2023, cracks were emerging and crypto bank Silvergate fell, following the failure of major depositor FTX, the now defunct crypto exchange founded by Sam Bankman-Fried.

The Silvergate collapse sparked widespread liquidity concerns, particularly in start-up and cryptocurrency exposed financial institutions.

Silicon Valley Bank was the next to fall after announcing plans to sell one of its smaller $US20 billion portfolios of US Treasuries at a $US2 billion loss.

“Depositors started getting really nervous and that led to a quiet but deadly electronic run on the bank that happened during the course of an afternoon, as the stock price continued to fall,” Chopra said.

“And then ultimately, over the course of the weekend depositors became more concerned about deposits and other financial institutions and similar situations happened with Signature Bank on that Friday, and then ultimately with First Republic.”

Just like Chopra’s slide had warned a year earlier, the banks had no way out.

While SVB marked the largest US bank collapse in more than a decade, it also resulted in Azora Capital’s best monthly return since its inception.

“In 2008 and 2009, 165 banks failed, comprising half a trillion dollars of assets. In the spring of this year, four banks failed, comprising half a trillion dollars of assets,” Chopra said.

Six months on and the industry is still feeling the shock.

“We did a survey of the top 50 financial institutions in the spring, and over 70 per cent of them said that they were tightening underwriting standards. That’s something I haven’t actually seen in my career, certainly not since the GFC,” Chopra added.

Meanwhile, the hedge fund is back to work, combing through regulatory filing and financial models, looking for the next opportunity.

“It’s often in row 500 of the Excel model on Tuesday night at 10pm that the proverbial light bulb goes off over our heads. That’s where the epiphanies are, that’s our secret sauce.”

Ravi Chopra is speaking at Sohn Hearts & Minds at the Sydney Opera House on November 17. All profits will support Australian medical research organisations. The Australian Financial Review is a media partner for sohnheartsandminds.com.au.

This article was originally posted by The Australian Financial Review here.

Licensed by Copyright Agency. You must not copy this work without permission.

Disclaimer: This material has been prepared by Australian Financial Review, published on Oct 16, 2023. HM1 is not responsible for the content of linked websites or content prepared by third party. The inclusion of these links and third-party content does not in any way imply any form of endorsement by HM1 of the products or services provided by persons or organisations who are responsible for the linked websites and third-party content. This information is for general information only and does not consider the objectives, financial situation or needs of any person. Before making an investment decision, you should read the relevant disclosure document (if appropriate) and seek professional advice to determine whether the investment and information is suitable for you.

facebook
linkedin
All
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
Daniel Loeb oversees $US11.7 billion ($18.5 billion) at New York-based Third Point. Picture: BloombergDaniel Loeb oversees $US11.7 billion ($18.5 billion) at New York-based Third Point. Picture: BloombergDaniel Loeb oversees $US11.7 billion ($18.5 billion) at New York-based Third Point. Picture: BloombergDaniel Loeb oversees $US11.7 billion ($18.5 billion) at New York-based Third Point. Picture: Bloomberg
October 23, 2023

Dan Loeb to headline Sohn Hearts & Minds

Famed hedge fund manager Dan Loeb has been named as one of the headline acts for next month’s Sohn Hearts & Minds philanthropic investment conference to be held in Sydney.

Read More
Ravi Chopra's Azora Capital had its best month in March when it shorted the US banks that failed. Picture: Jaclyn LichtRavi Chopra's Azora Capital had its best month in March when it shorted the US banks that failed. Picture: Jaclyn LichtRavi Chopra's Azora Capital had its best month in March when it shorted the US banks that failed. Picture: Jaclyn LichtRavi Chopra's Azora Capital had its best month in March when it shorted the US banks that failed. Picture: Jaclyn Licht
October 23, 2023

US Bank Run Has Slowed To A Walk, But Instability Remains

When Ravi Chopra reveals his stock pick at the prestigious Sohn Hearts & Minds conference at the Opera House in Sydney next month, it could well be a short bet on a US bank.

Read More
October 18, 2023

Two small caps: Propel Funeral Services (ASX: PFP) and Clarity Pharmaceuticals (ASX: CU6)

Get to know our 2023 Conference Fund Manager Rikki Bannan of IFM Investors who recently featured on the Equity Mates Media podcast.

Read More
IFM Investors executive director Rikki Bannan is a keen follower of stocks in the healthcare sector, but she knows it can be a risky place to invest.IFM Investors executive director Rikki Bannan is a keen follower of stocks in the healthcare sector, but she knows it can be a risky place to invest.IFM Investors executive director Rikki Bannan is a keen follower of stocks in the healthcare sector, but she knows it can be a risky place to invest.IFM Investors executive director Rikki Bannan is a keen follower of stocks in the healthcare sector, but she knows it can be a risky place to invest.
October 10, 2023

Beware the pitfalls of investing in healthcare, says IFM boss

“Healthcare is often viewed as a stable, defensive sector to invest in, but in small caps that hasn’t necessarily proven to be the case,” she says in an interview ahead of her appearance at the Sohn Hearts & Minds Conference 2023.

Read More
October 6, 2023

Secret to a long life cheaper than you think celebrity physician Peter Attia reveals

Don't miss Dr Peter Attia who will speak at the Sohn Hearts & Minds Conference at the Sydney Opera House next month.

Read More
Angela Aldrich of Bayberry Capital Partners in New York. Picture: Jaclyn Licht.Angela Aldrich of Bayberry Capital Partners in New York. Picture: Jaclyn Licht.Angela Aldrich of Bayberry Capital Partners in New York. Picture: Jaclyn Licht.Angela Aldrich of Bayberry Capital Partners in New York. Picture: Jaclyn Licht.
September 18, 2023

‘Volatility is opportunity’: why this manager loves shorting stocks

Angela Aldrich of Bayberry Capital Partners LP bet against Treasury Wine Estates at the top of the market and now she's preparing to make her next big call at this year's Sohn Hearts & Minds Conference.

Read More
September 15, 2023

Top fund managers share 11 stock picks for the long term

After a dramatic earnings season, fund managers, including Jessica Farr-Jones of Regal Funds and Kieran Moore of Munro Partners (HM1 Core Fund Managers), have shared some of their top picks for long-term growth.

Read More
September 11, 2023

Investors Sweeten On Hedge Funds As Rates Climb

After a decade of easy money pushing equity markets in one direction, Wall Street hedge fund manager Ricky Sandler says the return of volatility and higher interest rates is seeing money return to long-short strategies.

Read More
Eminence Capital CEO Ricky Sandler, left, with Sohn Australia co-founder Matthew Grounds. Picture: John FederEminence Capital CEO Ricky Sandler, left, with Sohn Australia co-founder Matthew Grounds. Picture: John FederEminence Capital CEO Ricky Sandler, left, with Sohn Australia co-founder Matthew Grounds. Picture: John FederEminence Capital CEO Ricky Sandler, left, with Sohn Australia co-founder Matthew Grounds. Picture: John Feder
September 11, 2023

Stock Stars Look Under The Surface

Influential New York-hedge fund manager Ricky Sandler returns to Australia to make a new pick at this year’s Sohn Hearts & Minds conference that will be held at the Sydney Opera House on November 17.

Read More
Barrenjoey co-executive chairman Matthew Grounds and New York-based Eminence Capital fund manager Ricky Sandler will be at the eighth Sohn Hearts & Minds conference. Picture: Peter RaeBarrenjoey co-executive chairman Matthew Grounds and New York-based Eminence Capital fund manager Ricky Sandler will be at the eighth Sohn Hearts & Minds conference. Picture: Peter RaeBarrenjoey co-executive chairman Matthew Grounds and New York-based Eminence Capital fund manager Ricky Sandler will be at the eighth Sohn Hearts & Minds conference. Picture: Peter RaeBarrenjoey co-executive chairman Matthew Grounds and New York-based Eminence Capital fund manager Ricky Sandler will be at the eighth Sohn Hearts & Minds conference. Picture: Peter Rae
September 11, 2023

Top Ny Stock Picker Warns Inflation To Remain Above Pre-Covid Levels

Influential New York hedge fund manager Ricky Sandler of Eminence Capital returns for the 2023 Sohn Hearts & Minds Conference in Sydney and says no one is focused on picking interesting, idiosyncratic stocks.

Read More
August 4, 2023

New Relic

New Relic was pitched by Ricky Sandler of Eminence Capital at the 2022 Sohn Hearts & Minds Conference.

Read More
June 18, 2023

Investors can’t agree how to value the world’s hottest stock

Despite mixed investor opinions, Munro Partners (Core Fund Manager) remains a strong believer in Nvidia. They are standing firm in their investment and still consider it a solid buy.

Read More
June 8, 2023

Stock pickers bet the field in slowing domestic market

Fund managers have batted away fears of an inflation-led recession, with Qantas, Seven Group and Treasury Wines named among the best investments by Australia’s top stock pickers.

Read More
March 27, 2023

The imaginary nepotism that drives Carsales global growth

The long-term approach of Carsales (2022 Conference stock pick) and its CEO Cameron McIntyre has delivered big gains for investors. He reveals his secret to staying strategic.

Read More
March 12, 2023

Jun Bei Liu is not giving up on the China reopening theme

Tribeca’s Jun Bei Liu says China’s reopening is only getting started, and names five ASX stocks set to benefit.

Read More
December 10, 2024

Professor Jane Butler: Sparking Hope for Spinal Cord Injuries

In this episode of the Hearts & Minds Podcast, we sit down with Professor Jane Butler to discuss her groundbreaking research into spinal cord injuries.

Read More
impact-podcasts
September 24, 2024

Asian Market Potential with Tom Naughton of Prusik

CIO Charlie Lanchester sits down with Tom Naughton, CIO of Prusik Investment Mgmt. Tom shares his investment philosophy, the opportunities and challenges in Asian markets, and how his 2023 conference stock pick, Swire Pacific (0019.HK), delivered an impressive 30% return.

Read More
investing
September 4, 2024

Building Hearts and Minds with Co-Founders Matthew Grounds and Guy Fowler

In this episode, co-founders Matthew Grounds AM and Guy Fowler OAM discuss their journey in building Hearts & Minds and its philanthropic model that has donated over $70 million to medical research.

Read More
investing
June 25, 2024

Navigating the Resource Sector with Jeremy Bond of Terra Capital

In this episode, we chat with Jeremy Bond, Founder of Terra Capital and HM1 Conference Fund Manager. Tune in for insights into the world of resource investments and the exciting opportunities that lie ahead.

Read More
investing
June 11, 2024

Prof. Nadia Badawi on Cerebral Palsy Breakthroughs and Neonatal Care

Dive deep into the groundbreaking work of Professor Nadia Badawi, an internationally recognised neonatologist and expert in Cerebral Palsy.

Read More
impact-podcasts
May 28, 2024

Investment Insights: Rikki Bannan on Top Picks and Trends

Join us for an engaging episode featuring Rikki Bannan, Portfolio Manager of IFM Investors and HM1 Conference Fund Manager. This episode explores Rikki's career journey, investment strategies, and her 2023 conference stock pick, Telix Pharmaceuticals (ASX.TLX).

Read More
investing
December 6, 2023

Peter Cooper talks building and instilling a culture of humility and excellence

In this episode, our guest is the renowned investor, Peter Cooper, founder and Chief Investment Officer of Cooper Investors (Core Fund Manager). A founding supporter of Hearts and Minds, Peter is a staunch advocate of our model and its philanthropic purpose, actively engaging in every facet of Hearts and Minds.

Read More
investing
November 28, 2023

Jun Bei Liu on her high conviction investment strategy

In this episode, HM1 Chief Investment Officer Charlie Lanchester is joined by Jun Bei Liu. Jun Bei is the Portfolio Manager of Tribeca’s Alpha Plus Fund and since taking over managing the Fund, she has quadrupled AUM.

Read More
investing
November 21, 2023

The world of rare genetic disease research

In this episode, we speak to Associate Professor Gina Ravenscroft. Gina is an Associate Professor in Neurogenetics at the Harry Perkins Institute of Medical Research in Perth. Her research interests are in rare genetic diseases, with a particular focus on neurogenetic diseases in babies and children.

Read More
impact-podcasts
November 14, 2023

Learn what makes a high conviction investment and how to avoid short-term noise

In this episode, our Core Fund Manager Magellan shares how they select top stocks for the HM1 portfolio.

Read More
investing
November 7, 2023

Delve into the world of kids critical care and trauma research

In thie episode, we are joined by Dr. Marino Festa, or Rino for short. He is the Medical Director of NSW Kids ECMO Referral Service and a senior specialist in Paediatric Intensive Care at Children’s Hospital at Westmead.

Read More
impact-podcasts
October 31, 2023

Where Regal's Phil King is searching for opportunities

HM1's CIO, Charlie Lanchester, talks to Phil King of Regal Funds about his passion for stocks, his ongoing search for opportunities, and some of the sectors he’s excited by right now. Phil King of Regal Funds, has been a tremendous supporter of Hearts & Minds since the beginning.

Read More
investing
October 24, 2023

Preventing recurrent miscarriages and birth defects

In this episode, CEO Paul Rayson is joined by renowned biomedical researcher Professor Sally Dunwoodie. Prof. Dunwoodie's groundbreaking work has revolutionised clinical practices and enabled genetic diagnostic tests worldwide. In 2017, her team achieved a double breakthrough with the potential to prevent recurrent miscarriages and various birth defects.

Read More
impact-podcasts
October 17, 2023

Nick Griffin on how he finds global winners

In this episode, CIO Charlie Lanchester chats with Nick Griffin, the founding partner and CIO of Munro Partners, one of HM1's Core Fund Managers. They go over his career to date, reflect on the lessons he’s learned, and trace the decisions that led to him starting Munro.

Read More
investing
October 10, 2023

How A/Prof Matt Call is teaching our body to kill cancer

In this episode, CEO Paul Rayson is joined by WEHI’s Associate Professor Matt Call to talk about his incredible research. Matt’s team teaches and trains the body's own immune cells to target and kill cancer cells.

Read More
impact-podcasts

No results found.

Please try a different search keyword or filter.